Literature DB >> 8254781

Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes.

C Tornatore1, K Meyers, W Atwood, K Conant, E Major.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection of the developing central nervous system results in a dementing process in children, termed HIV-1-associated encephalopathy. Infection of astroglial elements of the pediatric nervous system has been demonstrated and suggests that direct infection of some astrocytes may contribute to the neurologic deficit. In this model, HIV-1 establishes a persistent state of infection in astrocytes, which can be reactivated by the cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta). To better understand the natural history of viral persistence in astroglial cells, we characterized infection at the transcriptional level. The most abundant viral transcript during the establishment of persistence was the subgenomic multiply spliced 2-kb message, similar to mononuclear cell models of HIV-1 latency. Following reactivation with TNF-alpha or IL-1 beta the multiply spliced 2-kb message remained the most abundant viral transcript, in contrast to infected mononuclear cells in which reactivation leads to the reemergence of the 9- and 4-kb transcripts. Further characterization of the persistent 2-kb transcript by PCR amplification of in vitro-synthesized viral cDNA showed that, in the absence of cytokine stimulation, the most abundant multiply spliced transcripts were the Nef- and Rev-specific messages. However, following cytokine stimulation, double- and triple-spliced Tat-, Rev-, and Nef-specific messages could be identified. Immunohistochemical staining demonstrated that, during viral persistence, astrocytes expressed Nef protein but few or no viral structural proteins. These results demonstrate that viral persistence in astrocytes at the transcriptional level is fundamentally different from that seen in mononuclear cells and could account for the virtual absence of astroglial expression of viral structural antigens in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254781      PMCID: PMC236268     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus.

Authors:  M A Muesing; D H Smith; C D Cabradilla; C V Benton; L A Lasky; D J Capon
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

2.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  Progressive encephalopathy in children with acquired immune deficiency syndrome.

Authors:  L G Epstein; L R Sharer; V V Joshi; M M Fojas; M R Koenigsberger; J M Oleske
Journal:  Ann Neurol       Date:  1985-05       Impact factor: 10.422

4.  Inhibition of Rev-mediated HIV-1 expression by an RNA binding protein encoded by the interferon-inducible 9-27 gene.

Authors:  P Constantoulakis; M Campbell; B K Felber; G Nasioulas; E Afonina; G N Pavlakis
Journal:  Science       Date:  1993-02-26       Impact factor: 47.728

5.  Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef.

Authors:  O Schwartz; Y Rivière; J M Heard; O Danos
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution.

Authors:  J Embretson; M Zupancic; J Beneke; M Till; S Wolinsky; J L Ribas; A Burke; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

7.  Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes.

Authors:  B Kohleisen; M Neumann; R Herrmann; R Brack-Werner; K J Krohn; V Ovod; A Ranki; V Erfle
Journal:  AIDS       Date:  1992-12       Impact factor: 4.177

8.  Human immunodeficiency virus type 1 nef quasispecies in pathological tissue.

Authors:  B M Blumberg; L G Epstein; Y Saito; D Chen; L R Sharer; R Anand
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  The restricted nature of HIV-1 tropism for cultured neural cells.

Authors:  N Sharpless; D Gilbert; B Vandercam; J M Zhou; E Verdin; G Ronnett; E Friedman; M Dubois-Dalcq
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

10.  Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease.

Authors:  P Genis; M Jett; E W Bernton; T Boyle; H A Gelbard; K Dzenko; R W Keane; L Resnick; Y Mizrachi; D J Volsky
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  70 in total

1.  CD4/CXCR4-independent infection of human astrocytes by a T-tropic strain of HIV-1.

Authors:  B Schweighardt; J T Shieh; W J Atwood
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

Review 2.  Virus receptors in the human central nervous system.

Authors:  B Schweighardt; W J Atwood
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

3.  Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking.

Authors:  Maya Williams; Jeremiah F Roeth; Matthew R Kasper; Rebekah I Fleis; Chris G Przybycin; Kathleen L Collins
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

Review 5.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

6.  Detection of anti-tat antibodies in CSF of individuals with HIV-associated neurocognitive disorders.

Authors:  M Bachani; N Sacktor; J C McArthur; A Nath; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-01-18       Impact factor: 2.643

7.  Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells.

Authors:  F Canonne-Hergaux; D Aunis; E Schaeffer
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 8.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

Review 9.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

Review 10.  Where does HIV hide? A focus on the central nervous system.

Authors:  Melissa Churchill; Avindra Nath
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.